Article
Quantitative Assessment of the Subarachnoid Compartment in Correlation with the Development of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Search Medline for
Authors
Published: | June 9, 2017 |
---|
Outline
Text
Objective: With the traditional Fischer grade often being inconclusive in today’s multislice CT, imaging surrogates to evaluate the risk of cerebral vasospasm (VS) in aneurysmal subarachnoid (SAH) hemorrhage are still ill-defined. This study aimed to evaluate if quantitative measures of the subarachnoid compartment including hemorrhage and cerebrospinal-fluid (CSF) volumes correlate with the development of VS in SAH.
Methods: Over a 5-year period, 129 consecutive SAH-cases with repeat angiography taken on mean day 7±3 after ictus to clear clinical delayed cerebral ischemia (DCI) were retrospectively identified. Computer-assisted volumetric analysis was performed for SAH and CSF using an automatic segmentation tool on initial (<24h) CT scan after ictus. VS evident on repeat angiography after SAH defined primary outcome and regression analysis was performed for volumetric measures.
Results: Repeat angiography showed VS in 107 patients while VS was absent in 22 cases. Median Fischer grade was 4 (range 1-4, p=0.49) in both groups. SAH-grade (WFNS) showed a trend towards higher median values in patients with VS (3 vs. 2.5, range 1-5, p=0.06, respectively). Method of aneurysm occlusion (52 clipping vs. 74 coiling) had no association with VS (p=1.0). Patients with VS exhibited significantly greater clot volume and reduced CSF volume in the subarachnoid compartment compared to patients without VS (SAH: 34.0±30.0ml vs. 17.8±19.5ml, p<0.05 and CSF: 63.2±31.2ml vs. 90.5±61.7ml, p<0.01, respectively). Odds ratio (OR) to develop VS was increased 6-fold for patients with a SAH/CSF ratio above 0.25 (OR=6.1 95% C.I. 2.2 – 16.4, p<0.001).
Conclusion: Besides SAH volume, spare CSF had a strong association with VS, while Fischer grade failed to discriminate VS from non-VS patients. SAH/CSF ratio could serve as a promising surrogate for image-based risk-stratification for VS. This will help to customize neuromonitoring measures in patients at risk for VS after SAH. Clinical applicability and validity of SAH/CSF ratio has to be evaluated in future prospective series.